Aviragen Therapeutics, Inc. 4
4 · Aviragen Therapeutics, Inc. · Filed Aug 12, 2016
Insider Transaction Report
Form 4
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Transactions
- Award
Stock Option (Right to Buy)
2016-08-11$1.30/sh+380,000$494,000→ 1,478,929 totalExercise: $1.30From: 2017-08-11Exp: 2026-08-11→ Common Stock (380,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal annual installments beginning on the first anniversary and thereafter on the second and third anniversary ratably.